These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 10919885)

  • 1. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment.
    Eskelin S; Pyrhönen S; Summanen P; Hahka-Kemppinen M; Kivelä T
    Ophthalmology; 2000 Aug; 107(8):1443-9. PubMed ID: 10919885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
    Bedikian AY; Legha SS; Mavligit G; Carrasco CH; Khorana S; Plager C; Papadopoulos N; Benjamin RS
    Cancer; 1995 Nov; 76(9):1665-70. PubMed ID: 8635073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uveal melanoma: implications of tumor doubling time.
    Singh AD
    Ophthalmology; 2001 May; 108(5):829-31. PubMed ID: 11319992
    [No Abstract]   [Full Text] [Related]  

  • 4. Survival Rates in Patients After Treatment for Metastasis From Uveal Melanoma.
    Lane AM; Kim IK; Gragoudas ES
    JAMA Ophthalmol; 2018 Sep; 136(9):981-986. PubMed ID: 29955797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
    Süsskind D; Dürr C; Paulsen F; Kaulich T; Bartz-Schmidt KU
    Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic Ultrasonography for Surveillance in Patients With Uveal Melanoma.
    Choudhary MM; Gupta A; Bena J; Emch T; Singh AD
    JAMA Ophthalmol; 2016 Feb; 134(2):174-80. PubMed ID: 26633182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of patients and metastatic and local recurrent tumor growth in malignant melanoma of the uvea after ruthenium plaque radiotherapy.
    Summanen P; Immonen I; Heikkonen J; Tommila P; Laatikainen L; Tarkkanen A
    Ophthalmic Surg; 1993 Feb; 24(2):82-90. PubMed ID: 8446359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation.
    Al-Jamal RT; Eskelin S; Pyrhönen S; Kivelä T
    Acta Oncol; 2009; 48(3):476-9. PubMed ID: 19031163
    [No Abstract]   [Full Text] [Related]  

  • 9. Metastatic melanoma in the eye and orbit.
    Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E
    Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invited commentary. Uveal melanoma: implications of tumor doubling time.
    O'Brien J
    Ophthalmology; 2001 May; 108(5):831-2. PubMed ID: 11780648
    [No Abstract]   [Full Text] [Related]  

  • 11. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of ocular melanoma metastasis to the liver: the 2012 Zimmerman lecture.
    Grossniklaus HE
    JAMA Ophthalmol; 2013 Apr; 131(4):462-9. PubMed ID: 23392528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of liver metastases from uveal melanoma.
    Kodjikian L; Grange JD; Baldo S; Baillif S; Garweg JG; Rivoire M
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):985-93. PubMed ID: 15891893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uveal melanoma: a rare malignancy.
    Gragoudas ES; Egan KM
    Ophthalmology; 2000 Aug; 107(8):1441-2. PubMed ID: 10919884
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged survival after resection of liver metastases from uveal melanoma and intra-arterial chemotherapy.
    Kodjikian L; Grange JD; Rivoire M
    Graefes Arch Clin Exp Ophthalmol; 2005 Jun; 243(6):622-4. PubMed ID: 15650857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small metastasizing choroidal melanomas.
    Malclès A; Kivelä T; Svetlosakova Z; Jean-Louis B; Nguyen AM; Sallit R; Négrier S; Pommier P; Rivoire M; Chauvel P; Mammar H; Devouassoux-Shisheboran M; Kodjikian L; Denis P; Grange JD
    Acta Ophthalmol; 2015 Mar; 93(2):e160-6. PubMed ID: 25124923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Effects of Yttrium-90 Transarterial Radioembolization around Immunotherapy for Hepatic Metastases from Uveal Melanoma: A Preliminary Retrospective Case Series.
    Zheng J; Irani Z; Lawrence D; Flaherty K; Arellano RS
    J Vasc Interv Radiol; 2018 Oct; 29(10):1369-1375. PubMed ID: 30174161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variates of survival in metastatic uveal melanoma.
    Rietschel P; Panageas KS; Hanlon C; Patel A; Abramson DH; Chapman PB
    J Clin Oncol; 2005 Nov; 23(31):8076-80. PubMed ID: 16258106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival.
    Vogl T; Eichler K; Zangos S; Herzog C; Hammerstingl R; Balzer J; Gholami A
    J Cancer Res Clin Oncol; 2007 Mar; 133(3):177-84. PubMed ID: 17021903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed systemic recurrence of uveal melanoma.
    Kolandjian NA; Wei C; Patel SP; Richard JL; Dett T; Papadopoulos NE; Bedikian AY
    Am J Clin Oncol; 2013 Oct; 36(5):443-9. PubMed ID: 22706174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.